1. 1) Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin., 61, 69–90 (2011).
2. 2) Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet, 362, 1907–1917 (2003).
3. 3) Giunchedi P, Maestri M, Gavini E, Dionigi P, Rassu G. Transarterial chemoembolization of hepatocellular carcinoma–agents and drugs: an overview. Part 2. Expert Opin. Drug Deliv., 10, 799–810 (2013).
4. 4) Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell, 21, 283–296 (2012).
5. 5) Tang Z, Zhou X, Lin Z, Yang B, Ma Z, Ye S, Wu Z, Fan J, Liu Y, Liu K, Qin L, Tian J, Sun H, He B, Xia J, Qiu S, Zhou J. Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. Chin. Med. J. (Engl.), 112, 887–891 (1999).